Status:
COMPLETED
Virtual Reality-based Distraction to Reduce Distress in the Pediatric Emergency Department
Lead Sponsor:
University of Alberta
Conditions:
Children Requiring IV Placement
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Needle procedures, such as intravenous (IV) insertions, are among the most commonly performed procedures for children needing medical care. IV insertions are often a painful and stressful experience f...
Detailed Description
Objectives: The investigators' primary objective is to compare the reduction of distress with the use of distraction (via the VR intervention) versus current standard of care in children aged 6 to 17 ...
Eligibility Criteria
Inclusion
- We will include children presenting to the Stollery Children's Hospital ED, based on the eligibility criteria outlined below:
- child aged 6-17 years
- requires IV placement
- will receive topical anesthetic cream for IV placement
Exclusion
- medically unstable (CTAS 1, requires immediate IV insertion)
- unconscious or not fully alert
- visual, auditory or cognitive or mental health issues precluding safe interaction with the VR intervention
- conditions that could be exacerbated by the VR environment (as reported by the family), such as: (i) current symptomatic nausea / vomiting / dizziness / migraine; (ii) history of psychosis / hallucinations / epilepsy
- presence of an infection / injury which could contaminate the VR intervention equipment (as determined by the healthcare team) including but not limited to: (i) open wounds / infections of the head and neck area; (ii) suspected or confirmed methicillin-resistant Staphylococcus aureus (MRSA) colonization
- screens positive for 'influenza-like illness' (ILI) as per the current SCH ED screening criteria
- child or parental language barrier precluding the ability to understand and complete study assessments, in the absence of a native language translator
- previous enrollment in this study
Key Trial Info
Start Date :
September 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 12 2022
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04291404
Start Date
September 28 2020
End Date
February 12 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stollery Children's Hospital
Edmonton, Alberta, Canada